Literature DB >> 4137171

Reye's syndrome due to a novel protein-tolerant variant of ornithine-transcarbamylase deficiency.

M M Thaler, N J Hoogenraad, M Boswell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4137171     DOI: 10.1016/s0140-6736(74)91819-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Fatty liver: biochemical and clinical considerations.

Authors:  A M Hoyumpa; H L Greene; G D Dunn; S Schenker
Journal:  Am J Dig Dis       Date:  1975-12

2.  Reye syndrome or side-effects of anti-emetics?

Authors:  M Casteels-Van Daele
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

3.  Reye's Syndrome (Encephalopathy and Fatty Visceral Infiltration).

Authors:  M M Thaler
Journal:  West J Med       Date:  1976-01

4.  Immunological evidence for an ornithine transcarbamylase lesion resulting in the formation of enzyme with smaller protein subunits.

Authors:  N Hoogenraad; M Luisa de Martinis; D M Danks
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

5.  Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.

Authors:  Renata C Gallagher; Christina Lam; Derek Wong; Stephen Cederbaum; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-01-30       Impact factor: 4.406

6.  Reye's syndrome in an adult.

Authors:  R S Morse; A W Holmes; S Levin
Journal:  Am J Dig Dis       Date:  1975-12

7.  X-linked dominant inherited diseases with lethality in hemizygous males.

Authors:  R Wettke-Schäfer; G Kantner
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

Review 8.  Reye's syndrome: a clinical review.

Authors:  J F Crocker; P C Bagnell
Journal:  Can Med Assoc J       Date:  1981-02-15       Impact factor: 8.262

Review 9.  Ornithine transcarbamylase in liver mitochondria.

Authors:  M Mori; S Miura; T Morita; M Takiguchi; M Tatibana
Journal:  Mol Cell Biochem       Date:  1982-11-26       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.